The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux
Open accessThe DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index.
Abstract
Insulin resistance arises when the nutrient storage pathways evolved to maximize efficient energy utilization are exposed to chronic energy surplus. Ectopic lipid accumulation in liver and skeletal muscle triggers pathways that impair insulin signaling, leading to reduced muscle glucose uptake and decreased hepatic glycogen synthesis. Muscle insulin resistance, due to ectopic lipid, precedes liver insulin resistance and diverts ingested glucose to the liver, resulting in increased hepatic de novo lipogenesis and hyperlipidemia. Subsequent macrophage infiltration into white adipose tissue (WAT) leads to increased lipolysis, which further increases hepatic triglyceride synthesis and hyperlipidemia due to increased fatty acid esterification. Macrophage-induced WAT lipolysis also stimulates hepatic gluconeogenesis, promoting fasting and postprandial hyperglycemia through increased fatty acid delivery to the liver, which results in increased hepatic acetyl-CoA content, a potent activator of pyruvate carboxylase, and increased glycerol conversion to glucose. These substrate-regulated processes are mostly independent of insulin signaling in the liver but are dependent on insulin signaling in WAT, which becomes defective with inflammation. Therapies that decrease ectopic lipid storage and diminish macrophage-induced WAT lipolysis will reverse the root causes of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Supporting this perspective, monosaccharides have been shown to activate ChREBP and other key lipogenic transcription factors—including SREBP1c, LXR, and PPARγ—via insulin-independent mechanisms [34,70,83,86,99].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [99]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In both animal models and human patients, obesity‐induced hyperlipidaemia and lipotoxicity‐induced inflammation is thought to be one of the drivers for SO.[ 63 ]”
From Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review (2022) · cites this paper as [63]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In lipid infusion experiments, DAG content in the muscle increases, and consequently PKCθ is activated, resulting in limited phosphorylation of IRS-1 and glucose uptake through GLUT4 [9].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [9]
In the citing paper
“Insulin resistance is the core mechanism of sarcopenic obesity and is also associated with variable cardiometabolic diseases such as cardiovascular disease, type 2 diabetes mellitus, and non-alcoholic fatty liver disease.”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 1×
“Activated adipose tissue macrophages (ATMs) are recruited via chemokine signaling (96, 97) and release cytokines that promote lipolysis.”
BackgroundThe metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760 · cited 1×
“Activated adipose tissue macrophages (ATMs) are recruited via chemokine signaling (96, 97) and release cytokines that promote lipolysis.”
BackgroundLippa, N. C., & Sanderson, S. C. (2013) · Human Heredity · doi:10.1159/000353712 · Cited by 6,078
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093 · cited 2×
“Over a half century ago, Randle and colleagues concluded that muscle insulin resistance associated with obesity could be attributed to increased fatty acid oxidation that limits insulin-stimulated glucose utilization (43).”
BackgroundGenetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416 · cited 1×
“A common single nucleotide polymorphism (rs738409, I48M) in the lipid droplet protein patatin-like phospholipase domaincontaining protein 3 (PNPLA3, also called adiponutrin) has been associated with increased hepatic steatosis but not insulin resistance (74).”
BackgroundKim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Defining the role of mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.008 · Cited by 2,833 · cited 1×
“Insulin activates the insulin receptor tyrosine kinase (IRTK), with subsequent activation of kinases including 3-phosphoinositide-dependent kinase-1 (PDK1) and mTORC2 (6), which converge on Akt phosphorylation (6–8).”
BackgroundAlessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 2,826
Research works printed but not linked: 6
- 10.1210/jcem.87.8.8761 · doi:10.1210/jcem.87.8.8761 · Paper page
- Kersten, 2014, Physiological regulation of lipoprotein lipase, Biochim Biophys Acta, 1841, 919, 10.1016/j.bbalip.2014.03.013 · DOI · Paper page
- 10.1172/JCI10294 · DOI · Paper page
- 10.1172/JCI15001 · doi:10.1172/jci15001 · Paper page
- 10.1172/JCI19246 · doi:10.1172/jci19246 · Paper page
- 10.1172/JCI19451 · doi:10.1172/jci19451 · Paper page
Cited by
Items 901–998 of 998
Modern approaches to diagnostics of hyperandrogenism distributed forms in reproductive aged women
Бурка, О. А., & Tutchenko, T. М. (2019) · Reproductive Endocrinology · doi:10.18370/2309-4117.2019.46.39-45 · Cited by 6
Insulin Action, Insulin Resistance, and Their Link to Histone Acetylation
Balcerczyk, A., Chriett, S., & Pirola, L. (2017) · Springer eBooks · doi:10.1007/978-3-319-31143-2_57-1 · Cited by 6
Pathogenesis of Insulin Resistance and Glucose Intolerance in Childhood Obesity
Weiss, R., & Hagman, E. (2017) · Contemporary Endocrinology · doi:10.1007/978-3-319-68192-4_23 · Cited by 5
Liberty, I. A., Kurniawan, F., Wijaya, C. N., Soewondo, P., & Tahapary, D. L. (2024) · Diabetology · doi:10.3390/diabetology5060039 · Cited by 10
“Various pathways and molecular mechanisms have been implicated in insulin resistance, including chronic low-grade inflammation, mitochondrial dysfunction, and lipotoxicity [23].”
Msane, S., Khathi, A., & Sosibo, A. M. (2025) · Nutrients · doi:10.3390/nu17020292 · Cited by 6
Triglyceride glucose index and periodontitis: A nationwide study
Im, Y., Kim, N., & Chung, K. (2025) · Journal of Periodontology · doi:10.1002/jper.24-0490 · Cited by 5
Gupta, N., & Singh, K. (2025) · Journal of Molecular Histology · doi:10.1007/s10735-025-10507-2 · Cited by 6
“…metabolism and may offer therapeutic benefits in reduc - ing steatosis, inflammation and fibrosis in NASH (Yadav et al. 2022 Hence, targeting lipogenesis, adipokine modulation and insulin sensitivity represents a viable strategy for NAFLD treatment (Anwar et al. 2023; Samuel and Shulman 2016).”
The Role of Insulin Resistance in Cardiorenal Metabolic Syndrome
Xiao, J., Song, W. L., Huang, Y., He, X., Weng, Y., & Yu, H. (2025) · Cardiology in Review · doi:10.1097/crd.0000000000001048 · Cited by 5
Li, Z.-F., Yin, Z., Li, X., Lu, M.-Y., Zhang, W., Luo, F., Xu, Y.-L., Li, J., Dou, K.-F., Wang, X., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02910-6 · Cited by 5
“…regulation, IR plays a central role in lipid metabolism disorders by promoting hypertriglyceridemia, enhancing free fatty acid (FFA) flux from adipose to other tissues, and facilitating the accumulation of cholesterol-and TG-rich ApoB-containing lipoprotein remnants in the arterial wall [20, 21].”
Aging as the wound that fails to heal: a bioenergetic continuum of resolution failure
Tippairote, T., Hoonkaew, P., Suksawang, A., & Tippairote, P. (2025) · Biogerontology · doi:10.1007/s10522-025-10356-2 · Cited by 4
“Despite nutrient abundance, oxidative fuel flow to biosynthetic and reparative pathways diminishes, producing a condition of functional undernutrition—an energetic mis-allocation in which the machinery of repair starves amid plenty (Samuel & Shulman 2016; Smith et al. 2018; Tippairote et al. 2025).”
Endothelial Cell Regulation of Lipid Uptake During Feeding and Fasting
Goldberg, I. J., Tirumalasetty, M. B., Peche, V. S., Gaballa, R., Cabodevilla, A. G., Komack, M., Miao, Q., & Abumrad, N. A. (2025) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.125.323501 · Cited by 4
Wang, B., Shao, Y., & Liang, R. (2026) · Journal of Integrative Neuroscience · doi:10.31083/jin44389 · Cited by 5
Zou, X., Zhou, C., Zhou, R., Zhu, T., Zhao, J., Qing, W., Xie, J., Yu, R., Zhang, F., & Li, J. (2026) · Cardiovascular Diabetology · doi:10.1186/s12933-026-03080-9 · Cited by 4
“Furthermore, elevated TyG levels may reflect dysregulation in advanced glycation end-product metabolism and enhanced platelet reactivity, both of which impair endothelium-dependent vasodilation [50].”
Imaging-Derived Sarcopenic Obesity and Cardiovascular Outcomes
Sanghvi, M. M., Nicholls, H., Kaplan, T. M., Chadalavada, S., Ramírez, J., Stokes, T., Lim, C., Mcleod, J. C., Phillips, S. M., Phillips, B. E., et al. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2026.05.022 · Cited by 7
Association between sarcopenic obesity with insulin resistance and metabolic syndrome
Pérez‐Cruz, E., Castro-Martínez, D., & Guzmán, O. P. G. (2022) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2021.07.022 · Cited by 6
Li, T., Lv, Q., Liu, C., Li, C., Xie, X., & Zhang, W. (2024) · Molecules · doi:10.3390/molecules29071605 · Cited by 4
“However, in states of insulin resistance, the muscle’s ability to uptake glucose in response to insulin is significantly reduced, leading to persistently high blood glucose levels and potentially resulting in metabolic disorders such as type 2 diabetes [5,6].”
BackgroundEstimating the effect of lipid‐lowering agents on novel subtypes of adult‐onset diabetes
Ye, J., Guo, K., Li, J., Li, X., Zhou, Z., & Yang, L. (2024) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3793 · Cited by 5
Li, H., Li, C.-F., Liu, C., Chen, S., Liu, Y., Lv, Q., & Zhang, W. (2024) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-024-04592-1 · Cited by 7
“This leads to a persistent high level of blood glucose and can ultimately result in metabolic disorders such as type 2 diabetes [16, 18].”
BackgroundVieyra, E., Silva, C., Linares, R., Rosas, G., Espinoza, J.-A., Chaparro, A., Calderón, R., de la Peña, B., & Morales‐Ledesma, L. (2025) · Molecules · doi:10.3390/molecules30163407 · Cited by 6
“Insulin resistance is characterized by impaired glucose metabolism, which is mainly related to a reduction in insulin-mediated glucose uptake and dysregulation of lipolysis [27].”
Nonalcoholic Fatty Liver Disease: A Wide Spectrum Disease
Rosso, N., & Bellentani, S. (2020) · Springer eBooks · doi:10.1007/978-3-030-24432-3_26 · Cited by 4
Zafar, U. (2020) · Springer eBooks · doi:10.1007/978-3-030-53370-0_23 · Cited by 5
IRAK inhibitor can improve insulin sensitivity in insulin-resistant mice fed with a high-fat diet
Allahyari, M., Rajaie, A., & Fallah, H. (2020) · Asian Biomedicine · doi:10.1515/abm-2020-0034 · Cited by 4
“Insulin resistance and obesity-induced inflammation contribute substantially to the development of diseases such as atherosclerosis, nonalcoholic fatty liver, hypertension, hyperlipidemia, polycystic ovarian disease, and type 2 diabetes [8].”
Backgroundde Oliveira, D. A., Araújo, N. C. D. M., Freire, A. R., Albuquerque, G. S., Muniz, G. D. S., & do Nascimento, E. (2021) · Biological Rhythm Research · doi:10.1080/09291016.2021.1973203 · Cited by 6
“On the other hand, the high resistance to glucose decay to basal levels reinforces the possibility of insulin resistance (Lamia et al. 2008; Samuel and Shulman 2016).”
BackgroundTosi, M., Matelloni, I. A., Mancini, M., Andreassi, A., Scopari, A., Rossi, A., Verduci, E., Berra, C., Manfrini, R., Banderali, G., et al. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02088-2 · Cited by 6
“Reduced fasting insulin secretion and increased hepatic and renal insulin resistance are frequently linked to impaired fasting glucose (IFG) [41].”
Backgroundde Hart, N. M. M. P., Petrocelli, J. J., Nicholson, R. J., Yee, E. M., van Onselen, L., Lang, M. J., Bourrant, P., Ferrara, P. J., Bastian, E. D., Ward, L. S., et al. (2023) · Journal of Dairy Science · doi:10.3168/jds.2023-23914 · Cited by 4
“We investigated 2 tissues that contribute to the development of insulin resistance in obesity: liver and skeletal muscle (Samuel and Shulman, 2016).”
BackgroundWang, G., Yuan, H.-J., Kong, Q.-Q., Zhang, J., Xiao, H., Gong, S., Xu, M., He, N., Luo, M., & Tan, J. (2023) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2023.166921 · Cited by 4
Zhang, C., Liu, Z., Sun, K., Zhao, J., Huang, H., & Zhang, C. (2024) · Nutrition · doi:10.1016/j.nut.2024.112383 · Cited by 4
The Relationship Between Serum Lipids and the Formation of Colorectal Polyps
Düzköylü, Y., Demircioğlu, M. K., Kılavuz, H., & Sarı, S. (2024) · Cureus · doi:10.7759/cureus.57511 · Cited by 6
“Insulin resistance also increases TG and FSG levels with gluconeogenesis [28].”
BackgroundŁupińska, A., Aszkiełowicz, S., Kowalik, D., Jeziorny, K., Kolasa-Kicińska, M., Smalczewska, P., Zygmunt, A., Lewiñski, A., & Stawerska, R. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13102865 · Cited by 6
A nomogram to predict the risk of insulin resistance in Chinese women with polycystic ovary syndrome
Guo, B., Shen, Y., Dai, Z., Yimamu, K., Sun, J., & Pei, L. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1446827 · Cited by 6
Interventions Targeting Insulin Resistance in Patients with Type 1 Diabetes: A Narrative Review
Herascu, A., Avram, V. F., Gaiţă, L., Sima, A. C., Reurean‐Pintilei, D., & Timar, B. (2024) · Medicina · doi:10.3390/medicina60122067 · Cited by 6
Hou, Y., Guo, X., Yang, H., Li, H., Chen, R., Min, X., & Yu, J. (2025) · European journal of medical research · doi:10.1186/s40001-025-02629-w · Cited by 4
“Elevated free fatty acids could impair insulin activity and glucose utilization in peripheral tissues, potentially perpetuating a cycle of IR and dyslipidemia [37, 38].”
Nowosad, K., Ostrowska, M., Glibowski, P., Iłowiecka, K., & Koch, W. (2025) · Nutrients · doi:10.3390/nu17142377 · Cited by 8
“…central to the development of the androgen excess typical in PCOS, as hyperinsulinemia directly stimulates ovarian theca cells to produce androgens while suppressing the hepatic production of sex hormone-binding globulin (SHBG), thereby increasing the bioavailability of circulating androgens [6,7].”
Insulin Action, Insulin Resistance, and Their Link to Histone Acetylation
Balcerczyk, A., Chriett, S., & Pirola, L. (2019) · Springer eBooks · doi:10.1007/978-3-319-55530-0_57 · Cited by 4
Shebl, I., Kasem, H., Shehab-Eldin, W. A., Sonbol, A. E.-R., & Kamel, M. A. (2020) · Journal of The Egyptian Society of Nephrology and Transplantation · doi:10.4103/jesnt.jesnt_25_19 · Cited by 4
Azeez, T. A., & Osundina, M. A. (2020) · Journal of the Medical Sciences (Berkala Ilmu Kedokteran) · doi:10.19106/jmedsci005204202010 · Cited by 8
Alabi, T. D., Brooks, N. L., & Oguntibeju, O. O. (2020) · Herba Polonica · doi:10.2478/hepo-2020-0005 · Cited by 4
“Insulin resistance is a major factor that contributes to hepatic steatosis by inhibiting lipase thereby gaining control over free fatty acid release into the hepatocytes from the adipocytes [48, 49].”
BackgroundYaribeygi, H., Sathyapalan, T., Jamialahmadi, T., & Sahebkar, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-73234-9_26 · Cited by 6
Serum 25(OH)D Levels Modify the Association between Triglyceride and IR: A Cross-Sectional Study
Gong, R., Tang, X., Jiang, Z., Luo, G., Dong, C., & Han, X. (2022) · International Journal of Endocrinology · doi:10.1155/2022/5457087 · Cited by 4
“On the other hand, some studies have shown that excess triglycerides in the body promote ectopic lipid accumulation in the liver, skeletal muscle, and heart triggering impairment of insulin signaling pathways and hence inducing IR [44, 45].”
BackgroundFerreira, P. P. R., Silva, L. F. R., Dias‐Peixoto, M. F., Cassilhas, R. C., Gripp, F., Amorim, F. T., Mang, Z. A., Esteves, E. A., Tricoli, V., Ferraresi, C., et al. (2022) · Contemporary Clinical Trials Communications · doi:10.1016/j.conctc.2022.100984 · Cited by 4
Martyshina, A. V., & Dokukina, I. V. (2022) · Communications in computer and information science · doi:10.1007/978-3-031-24145-1_10 · Cited by 4
Association of prolactin and insulin with obesity in women with polycystic ovarian syndrome
Lavanya, K., Palaniappan, N., Vinodhini, V. M., Mahesh Kumar, K., & Silambanan, S. (2022) · Biomedicine · doi:10.51248/.v42i6.1613 · Cited by 7
Elkady, E. F., Jaadan, B. M., Ramadan, E., & Elmaaty, A. A. (2022) · Bioanalysis · doi:10.4155/bio-2022-0203 · Cited by 4
Akarsu, E., Sayıner, Z. A., Balcı, S. O., Demirel, C., Bozdağ, Z., Korkmaz, M., & Yilmaz, İ. (2023) · Revista da Associação Médica Brasileira · doi:10.1590/1806-9282.20220856 · Cited by 5
“Rev Assoc Med Bras 2023;69(1):112-118 has been a serious area of research.”
BackgroundMethodInfluentialFuke, N., Ushida, Y., Sato, I., & Suganuma, H. (2023) · Metabolites · doi:10.3390/metabo13030395 · Cited by 4
“Lipotoxicity is the phenomenon whereby fat accumulates ectopically in the liver or muscles rather than in adipose tissue, damaging those tissues and increasing their insulin resistance [43,44].”
BackgroundWang, P., Liu, Y., Kang, S. Y., Lyu, C., Han, X., Ho, T., Lee, K. J., Meng, X., Park, Y., & Jung, H. W. (2023) · Chinese Journal of Integrative Medicine · doi:10.1007/s11655-023-3548-9 · Cited by 4
“29-31) In addition, IR in the skeletal muscle transfers ingested glucose to the liver, increasing liver de novo lipogenesis and hyperlipidemia.”
Tan, W., Zhang, J., Deng, Z., Dai, F., Tang, L., Hu, W., & Liu, H. (2023) · Cancer Medicine · doi:10.1002/cam4.6073 · Cited by 4
Pi, S., Liu, A., Zhu, B., Zhu, Y., Yuan, J., Zhang, Z., Gao, C., Fu, J., Liu, Y., Liang, X., et al. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1102722 · Cited by 5
Kravchenko, L., Unhurian, L. M., Kotiuzhinska, S., Ivanova, Y., OBRAZENKO, M., Zahorodnia, L., & Yamilova, T. (2023) · Česká a slovenská farmacie · doi:10.5817/csf2023-6-296 · Cited by 4
Wang, G., Sun, J., Zhang, Y., Wang, N., Liu, T., Ji, W., Lv, L., Yu, X., Cheng, X., Li, M., et al. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1402386 · Cited by 7
“For example, diabetes is often linked with higher glucose levels due to insulin resistance and metabolic dysregulation (Samuel and Shulman, 2016).”
BackgroundGenetic Diversity of Insulin Resistance and Metabolic Syndrome
Lee, S., Ahn, J., Park, J., Na, H., Lee, Y.-K., Kim, Y., Hong, G., & Lee, K.-R. (2020) · IntechOpen eBooks · doi:10.5772/intechopen.93906 · Cited by 4
Extraction, purification, content analysis and hypoglycemic effect of mulberry marc anthocyanin
Yuan, K., Jin, S., Fang, J.-L., Jia, S., & Lin, Y. (2020) · Pharmacognosy Magazine · doi:10.4103/pm.pm_169_19 · Cited by 5
“In general, the TG was esterification by free fatty acids in peripheral circulation that released from fat tissues[32] or by acetyl‐CoA which is the glucose oxidation product.[33] Under normal physiological conditions, esterification of free fatty acids dominates the TG generation, followed by glycolipid conversion.”
BackgroundHan, A.-R., Kim, J.-H., Kim, E., Cui, J., Chai, I., Zhang, G., & Lee, Y. (2020) · Nutrition Research and Practice · doi:10.4162/nrp.2020.14.6.580 · Cited by 4
“, diacylglycerols) has been implicated in the pathogenesis of insulin resistance and could be a common denominator in the improved metabolic profile observed in the liver and muscle [17].”
BackgroundAzhar, R., Romdhoni, M. F., Karita, D., & Bahar, Y. (2022) · Muhammadiyah Journal of Geriatric · doi:10.24853/mujg.3.2.46-53 · Cited by 4
A Genetic Model to Study Increased Hexosamine Biosynthetic Flux
Hugo, S. E., & Schlegel, A. (2017) · Endocrinology · doi:10.1210/en.2017-00359 · Cited by 4
Cell-state dependent regulation of PPAR γ signaling by ZBTB9 in adipocytesPreprint
Xu, X., Charrier, A., Congrove, S., & Buchner, D. A. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.03.04.583402 · Cited by 4
Nilsson, I., Su, E. J., Fredriksson, L., Sahlgren, B. H., Bagoly, Z., Moessinger, C., Stefanitsch, C., Ning, F. C., Zeitelhofer, M., Muhl, L., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.11.617532 · Cited by 5
Nishino, K., Bloss, G., Kitzman, J. O., Parker, S. C. J., & Tovar, A. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.28.625886 · Cited by 4
Wang, J., Young, G., Zhang, M., Salvatore, S. R., Qin, F., Cai, X., Xu, M., Ke, M., Liu, L., Kim, J., et al. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110327 · Cited by 4
Hu, Y., Yu, J., Xu, Z., Gao, Y. H., Yang, L., & Li, L. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1530067 · Cited by 3
Mild Mitochondrial Uncoupling for True Ectopic Lipid Disposal
Lee, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26167740 · Cited by 4
“Critically, insulin resistance, a key precursor to metabolic diseases like type 2 diabetes, arises when the body’s energy storage systems are exposed to a chronic energy surplus, leads to a critical initial event: ectopic lipid accumulation [2].”
InfluentialZacharia, G. S., Ashraf, M. H., Sosa, F., Jacob, A., & Patel, H. (2025) · World Journal of Gastrointestinal Pharmacology and Therapeutics · doi:10.4292/wjgpt.v16.i4.110827 · Cited by 3
Metabolic and inflammatory axes of insulin resistance in normoglycemic adults with high HIV burden
Liweleya, S., Halubanza, B., Muchaili, L., Mweene, B. C., Siame, L., Lwiindi, P. C., Hamooya, B. M., Povia, J. P., Chabala, F. M., Sinkala, M., et al. (2026) · PLOS Global Public Health · doi:10.1371/journal.pgph.0005589 · Cited by 4
“…underscores the role of amino-acid dysregulation in the pathophysiology of metabolic dysfunction [33], while also acknowledging that reverse causality may contribute to the observed associations, that is, IR could directly increase gluconeogenesis, supported by enhanced protein turnover [34,35].”
Evaluating the therapeutic impact of tirzepatide in people with partial lipodystrophy
Mandour, M. O., Stears, A. J., van der Klaauw, A. A., Flanagan, C., Gaff, L., Jenkins, C., & Savage, D. B. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag126 · Cited by 4
Pan, Y., Bi, J., Feng, L., & He, X. (2026) · Journal of Health Population and Nutrition · doi:10.1186/s41043-026-01307-9 · Cited by 3
Chen, J., Liu, Z. W., Gu, J., Jiang, Y., Cao, K., Zhou, N., Zhou, Y., Wang, Z., Zhou, L., Yu, J., et al. (2026) · Nature Metabolism · doi:10.1038/s42255-026-01507-x · Cited by 3
“Once hepatocytes lose their sensitivity to insulin, termed hepatic insulin resistance (HIR), they cannot incorporate exogenous glucose into glycogen but even yield endogenous glucose, thus inactivating glycogenesis but activating gluconeogenesis 6,7 .”
From Lipids to Mitochondria: Shared Metabolic Alterations in Obesity and Alzheimer’s Disease
Uranga, R. M., & Allani, S. K. (2026) · Cells · doi:10.3390/cells15080672 · Cited by 3
“As glucose uptake in muscle declines, excess glucose is redirected to the liver, stimulating de novo lipogenesis and further exacerbating hyperlipidemia [64].”
Shafeeq, N. K., Hussein, T. A., & Abass, E. A. (2021) · Ibn AL- Haitham Journal For Pure and Applied Science · doi:10.30526/34.3.2675 · Cited by 7
Size matters: the biochemical logic of ligand type in endocrine crosstalk
Lone, J. B., Long, J. Z., & Svensson, K. J. (2023) · Life Metabolism · doi:10.1093/lifemeta/load048 · Cited by 6
Choi, J. W., Kim, T. H., Park, J.-S., & Lee, C. H. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14010089 · Cited by 3
“Impaired fasting glucose due to inappropriate endogenous glucose production originates from hepatic insulin resistance, reduced hepatic glucose clearance, and dysfunction of glucose uptake and production [30].”
BackgroundLRP1 facilitates hepatic glycogenesis by improving the insulin signaling pathway in HFD ‐fed mice
Guo, X., Pu, J., Tang, Z., Jia, C., Yang, F., Liu, T., & Ding, Y. (2024) · Animal Models and Experimental Medicine · doi:10.1002/ame2.12408 · Cited by 4
“5,8 LDL receptor-related protein-1 (LRP1) is an endocytic and signaling receptor containing an extracellular α - chain and a membrane-anchored cytoplasmic β - chain that functions in the regulation of various biological processes, including lipoprotein metabolism and vascular homeostasis,…”
BackgroundQuan, L., Guo, Y. J., Wang, S., Sun, M., Pang, Y., Cui, C., Wang, J., Wei, J., Wei, P.-F., & Xie, Y. (2024) · Medicinal Chemistry Research · doi:10.1007/s00044-024-03214-2 · Cited by 4
“…also referred to as dyslipidemia in the medical fi eld, is an elevation in the levels of triglycerides (TG) and/or total cholesterol (TC) in the blood, as well as an increase in low-density lipoprotein cholesterol (LDL-C) and a decrease in high-density lipoprotein cholesterol (HDL-C) [1, 2].”
Andavar, M., Kamaraj, R., Vijayakumar, T. M., & Murugesan, A. (2024) · Current Medical Research and Opinion · doi:10.1080/03007995.2024.2358237 · Cited by 3
“This leads to impairment of insulin signal transduction in the liver, muscles and adipose indirectly leading to insulin resistance, decrease in glucose uptake into the muscles and increase in the release of fatty acids into the bloodstream 54,55 .”
BackgroundYamarthi, P., Kotipalli, R., Patnaik, S. S., Veena, K. V., Kathirvel, M., Vutukuri, R., & Bhanoori, M. (2024) · Pathophysiology · doi:10.3390/pathophysiology31030031 · Cited by 3
“The liver is the main site for promotion of glycogenesis, inhibition of gluconeogenesis, and insulin clearance [28].”
BackgroundFeldman, F., Koudoufio, M., Sané, A. T., Marcil, V., Sauvé, M. F., Butcher, J., Patey, N., Martel, C., Spahis, S., Duan, H., et al. (2025) · Antioxidants · doi:10.3390/antiox14030268 · Cited by 5
“…in whether PAC impacted inflammation, as this has been shown to cause IR via the release of key pro-inflammatory markers, which impair the function of the insulin receptor on cell membranes, thereby reducing the power of insulin to bind effectively and activate its signaling pathways [74].”
Sevilla-González, M. D. R., Hanson, P. A., Islam, J., Hsu, S. C., Tsoukas, M. A., Marliss, E. B., Reiner, A. P., Gravel, M., Kooperberg, C. L., Clish, C. B., et al. (2025) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaf454 · Cited by 3
Natsir, R., Halimah, E., Diantini, A., & Levita, J. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s545571 · Cited by 5
Young, healthy South Asians have enhanced lipogenic sensitivity to dietary sugar
Hudgins, L. C., Hugo, J. L., Enayat, S., Parker, T. S., Artis, A. S., & Levine, D. M. (2016) · Clinical Endocrinology · doi:10.1111/cen.13293 · Cited by 3
Haidara, M. A., Al‐Ani, B., Bin‐Jaliah, I., ShamsEldeen, A. M., & Morsy, M. D. (2019) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2019.1691602 · Cited by 3
“…link between obesity, insulin resistance, and increased levels of oxidative stress and pro-inflammatory adipokines biomarkers such as leptin and IL-6 with vascular diseases were reported (Nseir et al. 2011, Samuel and Shulman 2016), and vanadium demonstrated beneficial effects in diabetes Figure 3.”
BackgroundCancer cachexia has many symptoms but only one cause: anoxia
Koltai, T. (2020) · F1000Research · doi:10.12688/f1000research.22624.1 · Cited by 3
Wang, X., Zhang, H., Zhang, P., Hao, S., Yang, X., & Zhou, X. (2021) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-021-04302-2 · Cited by 3
“It is well established that inflammatory cytokines could amplify inflammation response by various inflammatory signaling pathways and cause insulin resistance mediated by insulin signaling pathway [9].”
BackgroundsiRNA knockdown of angiopoietin 2 significantly reduces neovascularization in diabetic rats
Cabrera‐Becerra, S. E., Vera-Juárez, G., García-Rubio, V. G., Ocampo-Ortega, S. A., Blancas-Napoles, C. M., Méndez, A. A., Romero‐Nava, R., Huang, F., Hong, E., & Villafaña, S. (2022) · Journal of drug targeting · doi:10.1080/1061186x.2022.2052888 · Cited by 3
“the synthesis of hepatic glycogen, as well as augmented production of free fatty acids (FFAs) [37].”
BackgroundAl‐Taie, A., Arueyingho, O., Khoshnaw, J., & Hafeez, A. (2022) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2022.2086265 · Cited by 3
“Therefore, low muscle mass in sarcopenia may lead to a reduced capacity for glucose metabolism, particularly in older adults (Samuel and Shulman 2016).”
BackgroundMetabolic syndrome in primary care: A latent variable analysis of electronic medical records
Rathmann, W., Miller, R. E., Zingel, R., & Kostev, K. (2022) · Primary care diabetes · doi:10.1016/j.pcd.2022.08.007 · Cited by 3
Lin, C., Cheng, Y.-H., Lai, C.-N., & Tsai, C.-W. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105717 · Cited by 3
Vera-Ponce, V. J., Valencia, J. G., Poma, M. Á., Loayza-Castro, J. A., Zeñas-Trujillo, G. Z., Zuzunaga-Montoya, F. E., Torres-Malca, J. R., & Cruz-Vargas, J. A. D. L. (2023) · Medicina Clínica y Social · doi:10.52379/mcs.v7i3.292 · Cited by 7
Martyshina, A. V., Sirotkina, A. G., & Gosteva, I. V. (2024) · Biosystems · doi:10.1016/j.biosystems.2024.105227 · Cited by 3
Paschalidou, E., Katsaras, G. Ν., Papoulakis, T., Kalloniati, E., Kavvadas, D., Karachrysafi, S., Καπουκρανίδου, Δ., Tagarakis, G. I., & Papamitsou, T. (2024) · Clinics and Practice · doi:10.3390/clinpract14030081 · Cited by 5
“Forest plot: HOMA-IR before and after treatment with systemic isotretinoin [6,7,18–20, 22 , 23 , 26, 27 ,”
MethodTurvey, S., Muench, S. P., Issad, T., Fishwick, C. W. G., Kearney, M. T., & Simmons, K. J. (2024) · Growth Hormone & IGF Research · doi:10.1016/j.ghir.2024.101607 · Cited by 3
Nitric oxide in modulating oxidative stress mediated skeletal muscle insulin resistance
Anwar, A., Shukla, S., & Pathak, P. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09874-y · Cited by 6
“According to in vivo research, insulin increases tissue blood flow rates in healthy subjects by stimulating eNOS-mediated NO synthesis [41].”
InfluentialSilva, G. E. S., da Silva, S. S., Guimarães, D. S. P. S. F., da Cruz, M. V., Silveira, L. R., Rocha‐Vieira, E., Amorim, F. T., & Magalhães, F. D. C. (2024) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2024.101831 · Cited by 5
“This interference culminates in impairments in the ability of insulin to inhibit endogenous glucose production in the liver and to stimulate glucose uptake in skeletal muscle and adipose tissues, characterizing the condition of insulin resistance [9].”
BackgroundCao, C., Han, Y. Y., Deng, H., Zhang, X., Hu, H., Zha, F., & Wang, Y. (2024) · European journal of medical research · doi:10.1186/s40001-024-02121-x · Cited by 3
“Elevated triglycerides facilitate the movement of high levels of free fatty acids to the liver, augmenting glucose production and specifically enhancing gluconeogenesis [28].”
BackgroundAsllanaj, E., Ochoa‐Rosales, C., Glišić, M., Nano, J., Muka, T., & Franco, O. H. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814259-2.00012-1 · Cited by 4
Aicda deficiency exacerbates high-fat diet-induced hyperinsulinemia but not gut dysbiosis in mice
Tsuruta, T., Muhomah, T. A., Sonoyama, K., Nguyen, Q. D., Takase, Y., Nishijima, A., Himoto, S., KATSUMATA, E., & Nishino, N. (2021) · Nutrition Research · doi:10.1016/j.nutres.2021.06.009 · Cited by 3
The Role of Positron Emission Tomography in Bariatric Surgery Research: a Review
Bini, J., Norcross, M., Cheung, M., & Duffy, A. J. (2021) · Obesity Surgery · doi:10.1007/s11695-021-05576-7 · Cited by 3
“The complexity of these complete pathways in healthy individuals, and during insulin resistance and T2D, has been previously reviewed [62].”
BackgroundInfluentialBuckels, E. J., Bloomfield, F. H., Oliver, M. H., Spiroski, A., Harding, J. E., & Jaquiery, A. L. (2021) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00111.2021 · Cited by 3
Mechanisms of improved glucose handling after metabolic surgery: the big 6
Paszkiewicz, R. L., & Bergman, R. N. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.03.008 · Cited by 3
Jin, L., Cui, Y., Zhang, Q., Xiong, Y., Zheng, X., Ye, J., Zhang, A., Xiao, Z., Zhuang, Z., Liang, G., et al. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114053 · Cited by 1
Metadata
- Authors
- Samuel, V. T., & Shulman, G. I.
- Affiliations
- Veterans Health Administration (US)
- Howard Hughes Medical Institute (US)
- Venue
- Journal of Clinical Investigation
- Published
- 2016-01-04
- Volume
- 126
- Issue
- 1
- Pages
- 12-22
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC4701542
- OpenAlex
- W2230222215
- Cited by
- 1,484
- References
- 131
- Citations by year
- 2026: 192 · 2025: 162 · 2024: 152 · 2023: 150 · 2022: 150 · 2021: 143 · 2020: 134 · 2019: 136 · 2018: 114 · 2017: 99 · 2016: 51
- FWCI
- 18.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs (I01 BX000901)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-49230, R01DK049230, DK40936, DK 45735, R01DK040936, U24DK059635, R24DK085638, DK059635, DK-085638, P30DK045735)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- insulin resistance, type 2 diabetes, ectopic fat deposition, hepatic insulin signaling, skeletal muscle glucose uptake, hepatic gluconeogenesis, hepatic de novo lipogenesis, adipose tissue lipolysis, hepatic triglyceride synthesis, fatty acid esterification, hyperlipidemia, hyperglycemia, pyruvate carboxylase, acetyl-CoA, substrate flux, inflammation, energy surplus
- MeSH terms
- Adipose Tissue, Animals, Glucose, Humans, Insulin Resistance, Liver, Triglycerides, Signal Transduction, Muscle, Skeletal, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.